NCT05484622 2026-03-12Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant GliomaServierPhase 1 Active not recruiting60 enrolled
NCT07235748 2026-02-17Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult ParticipantsServierPhase 1 Completed28 enrolled